Common use of Scope of License Grant Clause in Contracts

Scope of License Grant. You may install the Software, and use the Software on your computer solely for the following purposes depending upon the “License Type” as checked hereunder: Evaluation License: During such evaluation, you may use the software in order to evaluate it for purchase or for demonstration purposes. You may not use the Software, or any results derived thereof, for any purpose, commercial or otherwise, other than for evaluation of the Software. Such use is forbidden both during and after the evaluation period unless the software is purchased during or immediately after the License Period. Likewise, unless the software is purchased during or immediately after the License Period, you may not disclose and/or publish results obtained with the Software without the express written permission of QuantumBio. The License Period for the Evaluation License is one (1) month from the Effective Date. Annual License: You are granted a one year, annually renewable, nonexclusive license for concurrent users to install and use the Software for in-house drug research and design purposes only performed at the site(s) listed below under “Site Address(es) for Use of Software.” By “one year, annually renewable” is meant that the initial License Period is one year from the Effective Date and the license will be automatically renewed for successive one year License Periods unless either party terminates the license by notice to the other party. You may use the Software for the License Period, and any results derived there from for the License Period and thereafter, for any purpose, commercial or otherwise. During and after the License Period, you may disclose and/or publish results obtained with the Software. Consultancy License: You are granted a consultancy license according to the attached Consultancy Appendix. All other terms noted on this full agreement are in full force.

Scope of License Grant. You may install the Software, and use the Software on your computer solely for the following purposes depending upon the “License Type” as checked hereunder: Evaluation License: During such evaluation, you may use the software in order to evaluate it for purchase or for demonstration purposes. You may not use the Software, or any results derived thereof, for any purpose, commercial or otherwise, other than for evaluation of the Software. Such use is forbidden both during and after the evaluation period unless the software is purchased during or immediately after the License Period. Likewise, unless the software is purchased during or immediately after the License Period, you may not disclose and/or publish results obtained with the Software without the express written permission of QuantumBio. The License Period for the Evaluation License is one (1) month from the Effective Date. Annual Commercial License: You are granted a one year, annually renewable, nonexclusive renewable license for concurrent users user(s) to install and use the Software for in-house drug research and design purposes only performed at the site(s) listed below under “Site Address(es) for Use of Software.” By “one year, annually renewable” is meant that the initial License Period is one year from the Effective Date and the license will be automatically renewed for successive one year License Periods unless either party terminates the license by notice to the other party. You may use the Software for the License Period, and any results derived there from for the License Period and thereafter, for any purpose, commercial or otherwise. During and after the License Period, you may disclose and/or publish results obtained with the Software. Academic/Non-Profit License: You are granted a one-year, annually renewable, nonexclusive license for non-profit use according to attached Academic/Non-profit Appendix. All other terms noted on this full agreement are in full force. Commercial Consultancy License: You are granted a consultancy license according to the attached Consultancy Appendix. All other terms noted on this full agreement are in full force.